Steward Partners Investment Advisory, LLC Repligen Corp Transaction History
Steward Partners Investment Advisory, LLC
- $10.6 Billion
- Q3 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Repligen Corp stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 93 shares of RGEN stock, worth $15,427. This represents 0.0% of its overall portfolio holdings.
Number of Shares
93
Previous 58
60.34%
Holding current value
$15,427
Previous $7,000
85.71%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RGEN
# of Institutions
485Shares Held
54.1MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.26 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$1.06 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$837 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$269 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$236 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $9.21B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....